ArticleInternational journal of clinical and experimental pathology2026
The clinical recognition, diagnosis and treatment of osteogenesis imperfecta: a case report and literature review.
Article in International journal of clinical and experimental pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteogenesis imperfecta (OI) is a rare congenital heterogeneous connective tissue disorder characterized by increased bone fragility, recurrent fractures, skeletal deformities, and short stature. Timely diagnosis and intervention can improve patients' quality of life and enhance their long-term prognosis. This study reports a case of a 26-year-old patient with OI who also had autoimmune diseases. Due to long-term treatment with glucocorticoids for autoimmune diseases, the OI was chronically missed. The typical clinical symptoms, skeletal imaging features, and genetic test results of this patient ultimately confirmed the diagnosis of osteogenesis imperfecta. At the same time, a multidisciplinary comprehensive individualized treatment plan was formulated and implemented for the patient, effectively alleviating clinical symptoms and improving the prognosis of the disease. This study reports a case of an adult patient with OI who also has an autoimmune disease. It emphasizes the need for clinicians to pay attention to the early identification and genetic diagnosis of OI in the context of co-morbidity. Multidisciplinary comprehensive treatment can significantly improve the patient's symptoms, providing a reference for the clinical diagnosis and treatment of rare hereditary bone diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.